Montanova Capital
New York, NYfiles as MONTANOVA CAPITAL, LLC
$4.8bn in 95 US stocks at the end of 30 June 2026. The top 10 are 44.6% of the money. It changed about 22.2% of the portfolio this quarter.
Value
$4.8bn
Stocks
95
Top 10 share
44.6%
Turnover
22.2%
What changed this quarter
New
Bought for the first time this quarter.
- Avalyn PharmaAVLN1.7% of the fund
- Hut 8HUT1.6% of the fund
- AmphenolAPH1.0% of the fund
- Roundhill ETF TrustDRAM0.9% of the fund
- Cerebras SystemsCBRS0.8% of the fund
- Dick's Sporting GoodsDKS0.7% of the fund
- BroadcomAVGO0.7% of the fund
- Space Exploration TechnologiesSPCX0.4% of the fund
- Martin Marietta MaterialsMLM0.3% of the fund
- Planet FitnessPLNT0.2% of the fund
- Bloom EnergyBE0.2% of the fund
- KardiganKARD0.2% of the fund
- CVS HealthCVS0.2% of the fund
- CenteneCNC0.1% of the fund
- Celldex TherapeuticsCLDX<0.1% of the fund
- Trulieve CannabisTRLV<0.1% of the fund
- Lam ResearchLRCX<0.1% of the fund
- SnowflakeSNOW<0.1% of the fund
- AlphabetGOOG<0.1% of the fund
- Charles River Laboratories InternationalCRL<0.1% of the fund
- InMed PharmaceuticalsINM<0.1% of the fund
Added
Bought more of a stock they already held.
- ArriVent BioPharmaAVBP3.3% of the fund+3%
- NvidiaNVDA3.0% of the fund+25%
- SyscoSYY2.5% of the fund+22%
- MGM Resorts InternationalMGM2.3% of the fund+8%
- Meta PlatformsMETA2.1% of the fund+4%
- Capricor TherapeuticsCAPR2.1% of the fund+7%
- Home DepotHD1.7% of the fund+2%
- Capital One FinancialCOF1.4% of the fund+10%
- Vulcan MaterialsVMC1.3% of the fund+18%
- Ferguson EnterprisesFERG1.2% of the fund+16%
- Zura BioZURA1.2% of the fund+4%
- InflaRxIFRX1.1% of the fund+189%
- Aura BiosciencesAURA1.1% of the fund+65%
- Faeth TherapeuticsFTH1.1% of the fund+5747%
- Advisorshares TRMSOS1.0% of the fund+8%
- Replimune GroupREPL1.0% of the fund+4%
- Spotify TechnologySPOT1.0% of the fund+9155%
- Crinetics PharmaceuticalsCRNX0.9% of the fund+14%
- Lexeo TherapeuticsLXEO0.6% of the fund+411%
- Whitehawk TherapeuticsWHWK0.4% of the fund+16%
- DexcomDXCM0.1% of the fund+222%
- Boston ScientificBSX0.1% of the fund+13%
- Intuitive SurgicalISRG0.1% of the fund+20%
Cut
Sold some of their stake.
- Legend BiotechLEGN4.3% of the fund-7%
- Arcus BiosciencesRCUS3.1% of the fund-5%
- Monte Rosa TherapeuticsGLUE1.8% of the fund-16%
- Amazon.comAMZN1.0% of the fund-19%
- Bank of AmericaBAC0.9% of the fund-39%
- UnitedHealth GroupUNH0.6% of the fund-36%
- Fulcrum TherapeuticsFULC0.3% of the fund-44%
- DanaherDHR0.1% of the fund-27%
- Mineralys TherapeuticsMLYS<0.1% of the fund-89%
- Abeona TherapeuticsABEO<0.1% of the fund-81%
- Johnson & JohnsonJNJ<0.1% of the fund-67%
- Performance Food GroupPFGC<0.1% of the fund-96%
- W.W. GraingerGWW<0.1% of the fund-23%
- US Foods HoldingUSFD<0.1% of the fund-98%
Sold out
Sold their entire stake.
- Apellis Pharmaceuticals-100%
- Kalvista Pharmaceuticals-100%
- ErascaERAS-100%
- Life Time Group HoldingsLTH-100%
- WingstopWING-100%
- CoherentCOHR-100%
- MedtronicMDT-100%
- Kezar Life Sciences-100%
- Mettler Toledo InternationalMTD-100%
- TeslaTSLA-100%
- Talen EnergyTLN-100%
- VistraVST-100%
- RobloxRBLX-100%
- Viridian TherapeuticsVRDN-100%
Holdings
- Legend BiotechLEGN
- Share
- 4.3%
- Value
- $204m
- Shares
- 7,070,000
-7%
- Avalyn PharmaAVLN
- Share
- 1.7%
- Value
- $82m
- Shares
- 2,503,109
New
- Advisorshares TRMSOS
- Share
- 1.0%
- Value
- $49m
- Shares
- 9,738,524
+8%
- Roundhill ETF TrustDRAM
- Share
- 0.9%
- Value
- $45m
- Shares
- 603,000
New
- Crinetics PharmaceuticalsCRNX
- Share
- 0.9%
- Value
- $44m
- Shares
- 1,186,279
+14%
- Cerebras SystemsCBRS
- Share
- 0.8%
- Value
- $38m
- Shares
- 171,900
New
- Space Exploration TechnologiesSPCX
- Share
- 0.4%
- Value
- $17m
- Shares
- 101,200
New
- KardiganKARD
- Share
- 0.2%
- Value
- $10m
- Shares
- 400,000
New
- Molecular Partners AGMOLN
- Share
- 0.2%
- Value
- $9m
- Shares
- 2,221,494
Held
- Satellos BioscienceMSLE
- Share
- <0.1%
- Value
- $4m
- Shares
- 475,000
Held
| Company | Share of fund | Value | Shares | Change |
|---|---|---|---|---|
| VeradermicsMANE | 10.8% | $513m | 4,168,970 | Held |
| Arcutis BiotherapeuticsARQT | 6.9% | $326m | 12,437,000 | Held |
| Legend BiotechLEGN | 4.3% | $204m | 7,070,000 | -7% |
| Palvella TherapeuticsPVLA | 3.6% | $174m | 1,135,406 | Held |
| ArriVent BioPharmaAVBP | 3.3% | $157m | 4,515,531 | +3% |
| Benitec BiopharmaBNTC | 3.2% | $155m | 11,548,351 | Held |
| BiohavenBHVN | 3.2% | $153m | 10,286,937 | Held |
| Advanced Micro DevicesAMD | 3.1% | $149m | 257,240 | Held |
| Arcus BiosciencesRCUS | 3.1% | $147m | 4,776,423 | -5% |
| Taiwan Semiconductor ManufacturingTSM | 3.1% | $145m | 304,627 | Held |
| NvidiaNVDA | 3.0% | $144m | 720,609 | +25% |
| EyePointEYPT | 2.5% | $119m | 8,296,375 | Held |
| SyscoSYY | 2.5% | $118m | 1,411,550 | +22% |
| General ElectricGE | 2.4% | $116m | 310,262 | Held |
| ImmaticsIMTX | 2.4% | $113m | 11,190,129 | Held |
| MGM Resorts InternationalMGM | 2.3% | $111m | 2,325,360 | +8% |
| Meta PlatformsMETA | 2.1% | $99m | 175,807 | +4% |
| Capricor TherapeuticsCAPR | 2.1% | $99m | 4,092,784 | +7% |
| Kura OncologyKURA | 2.0% | $94m | 8,575,422 | Held |
| Monte Rosa TherapeuticsGLUE | 1.8% | $86m | 3,549,539 | -16% |
| Avalyn PharmaAVLN | 1.7% | $82m | 2,503,109 | New |
| Home DepotHD | 1.7% | $80m | 226,053 | +2% |
| Hut 8HUT | 1.6% | $77m | 670,000 | New |
| Capital One FinancialCOF | 1.4% | $67m | 333,098 | +10% |
| Vulcan MaterialsVMC | 1.3% | $63m | 214,978 | +18% |
| Ferguson EnterprisesFERG | 1.2% | $59m | 246,758 | +16% |
| Zura BioZURA | 1.2% | $56m | 9,443,001 | +4% |
| InflaRxIFRX | 1.1% | $51m | 22,933,910 | +189% |
| Aura BiosciencesAURA | 1.1% | $51m | 7,206,217 | +65% |
| Faeth TherapeuticsFTH | 1.1% | $51m | 2,020,103 | +5747% |
| Advisorshares TRMSOS | 1.0% | $49m | 9,738,524 | +8% |
| Amazon.comAMZN | 1.0% | $49m | 204,860 | -19% |
| Replimune GroupREPL | 1.0% | $49m | 4,389,836 | +4% |
| AmphenolAPH | 1.0% | $47m | 269,300 | New |
| Spotify TechnologySPOT | 1.0% | $47m | 101,800 | +9155% |
| Contineum TherapeuticsCTNM | 1.0% | $47m | 2,841,334 | Held |
| Apollo Global ManagementAPO | 1.0% | $45m | 383,300 | Held |
| Bank of AmericaBAC | 0.9% | $45m | 789,720 | -39% |
| Roundhill ETF TrustDRAM | 0.9% | $45m | 603,000 | New |
| Crinetics PharmaceuticalsCRNX | 0.9% | $44m | 1,186,279 | +14% |
| Cerebras SystemsCBRS | 0.8% | $38m | 171,900 | New |
| Dick's Sporting GoodsDKS | 0.7% | $34m | 151,320 | New |
| BroadcomAVGO | 0.7% | $32m | 83,600 | New |
| Compass TherapeuticsCMPX | 0.6% | $31m | 14,101,159 | Held |
| Lexeo TherapeuticsLXEO | 0.6% | $30m | 6,384,200 | +411% |
| UnitedHealth GroupUNH | 0.6% | $27m | 64,130 | -36% |
| ProkidneyPROK | 0.5% | $25m | 12,341,266 | Held |
| Whitehawk TherapeuticsWHWK | 0.4% | $20m | 4,300,000 | +16% |
| Space Exploration TechnologiesSPCX | 0.4% | $17m | 101,200 | New |
| Martin Marietta MaterialsMLM | 0.3% | $15m | 26,000 | New |
| Fulcrum TherapeuticsFULC | 0.3% | $13m | 3,680,921 | -44% |
| Planet FitnessPLNT | 0.2% | $11m | 219,910 | New |
| Bloom EnergyBE | 0.2% | $10m | 33,800 | New |
| KardiganKARD | 0.2% | $10m | 400,000 | New |
| CVS HealthCVS | 0.2% | $9m | 84,500 | New |
| Molecular Partners AGMOLN | 0.2% | $9m | 2,221,494 | Held |
| Anteris Technologies GlobalAVR | 0.2% | $8m | 850,000 | Held |
| DexcomDXCM | 0.1% | $7m | 101,980 | +222% |
| Thermo Fisher ScientificTMO | 0.1% | $7m | 13,400 | Held |
| CenteneCNC | 0.1% | $6m | 99,100 | New |
| Abbott LaboratoriesABT | 0.1% | $6m | 66,920 | Held |
| Boston ScientificBSX | 0.1% | $6m | 140,083 | +13% |
| Intuitive SurgicalISRG | 0.1% | $5m | 13,600 | +20% |
| DanaherDHR | 0.1% | $5m | 26,600 | -27% |
| Mineralys TherapeuticsMLYS | <0.1% | $5m | 173,886 | -89% |
| Celldex TherapeuticsCLDX | <0.1% | $5m | 121,297 | New |
| Satellos BioscienceMSLE | <0.1% | $4m | 475,000 | Held |
| CencoraCOR | <0.1% | $4m | 12,488 | Held |
| Trulieve CannabisTRLV | <0.1% | $4m | 356,100 | New |
| Abeona TherapeuticsABEO | <0.1% | $3m | 500,000 | -81% |
| NateraNTRA | <0.1% | $3m | 10,100 | Held |
| Johnson & JohnsonJNJ | <0.1% | $2m | 7,700 | -67% |
| Lam ResearchLRCX | <0.1% | $2m | 4,302 | New |
| MicrosoftMSFT | <0.1% | $2m | 4,970 | Held |
| StrykerSYK | <0.1% | $2m | 5,860 | Held |
| Edwards LifesciencesEW | <0.1% | $2m | 18,700 | Held |
| MedlineMDLN | <0.1% | $2m | 42,500 | Held |
| Performance Food GroupPFGC | <0.1% | $2m | 14,710 | -96% |
| SnowflakeSNOW | <0.1% | $1m | 5,600 | New |
| Iqvia HoldingsIQV | <0.1% | $1m | 7,175 | Held |
| MckessonMCK | <0.1% | $1m | 1,830 | Held |
| HCA HealthcareHCA | <0.1% | $1m | 3,190 | Held |
| WatersWAT | <0.1% | $1m | 3,225 | Held |
| AlphabetGOOG | <0.1% | $1m | 3,400 | New |
| W.W. GraingerGWW | <0.1% | $1m | 770 | -23% |
| Ionis PharmaceuticalsIONS | <0.1% | $856,332 | 10,800 | Held |
| US Foods HoldingUSFD | <0.1% | $707,570 | 6,920 | -98% |
| Agilent TechnologiesA | <0.1% | $662,822 | 4,990 | Held |
| VeraltoVLTO | <0.1% | $485,523 | 5,475 | Held |
| ResmedRMD | <0.1% | $465,763 | 2,390 | Held |
| SterisSTE | <0.1% | $322,172 | 1,530 | Held |
| Sarepta TherapeuticsSRPT | <0.1% | $321,447 | 17,888 | Held |
| Zimmer Biomet HoldingsZBH | <0.1% | $280,653 | 3,260 | Held |
| Charles River Laboratories InternationalCRL | <0.1% | $229,058 | 1,010 | New |
| InMed PharmaceuticalsINM | <0.1% | $155,000 | 100,000 | New |
Options (1)
- State STR Spdr S&P 500 ETF TSPY
- Type
- Put
- Value
- $709m
- Contracts
- 950,000
| Company | Type | Value | Contracts |
|---|---|---|---|
| State STR Spdr S&P 500 ETF TSPY | Put | $709m | 950,000 |
Over time and by industry
Value over time
Jun '25
Dec '25
Jun '26
Value is up 79.3% since 30 June 2025.
Where the money is
Health care59.3%
Technology12.2%
Retail & consumer6.0%
Financial services4.9%
Industrials3.9%
Media & telecom3.1%
Everyday goods2.5%
Materials1.6%
Other6.4%
From the fund's 13F filings. They list US stocks and options only, 45 days after each quarter, and leave out cash, bonds, shorts and foreign shares.